Literature DB >> 33806554

Semi-Synthesis of Harringtonolide Derivatives and Their Antiproliferative Activity.

Xiutao Wu1, Lijie Gong1, Chen Chen1, Ye Tao1, Wuxi Zhou1, Lingyi Kong1, Jianguang Luo1.   

Abstract

Harringtonolide (HO), a natural product isolated from Cephalotaxus harringtonia, exhibits potent antiproliferative activity. However, little information has been reported on the systematic structure-activity relationship (SAR) of HO derivatives. Modifications on tropone, lactone, and allyl positions of HO (1) were carried out to provide 17 derivatives (2-13, 11a-11f). The in vitro antiproliferative activity against four cancer cell lines (HCT-116, A375, A549, and Huh-7) and one normal cell line (L-02) was tested. Amongst these novel derivatives, compound 6 exhibited comparable cell growth inhibitory activity to HO and displayed better selectivity index (SI = 56.5) between Huh-7 and L-02 cells. The SAR results revealed that the tropone and lactone moieties are essential for the cytotoxic activities, which provided useful suggestions for further structural optimization of HO.

Entities:  

Keywords:  antiproliferative activity; harringtonolide; structure-activity relationship (SAR); troponoids

Year:  2021        PMID: 33806554      PMCID: PMC7961763          DOI: 10.3390/molecules26051380

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  2 in total

1.  Photoaffinity Probe Reveals the Potential Target of Harringtonolide for Cancer Cell Migration Inhibition.

Authors:  Tian-Yu Zhu; Xiu-Tao Wu; Chen Chen; Xiao-Qin Liu; Li Zhu; Jian-Guang Luo; Ling-Yi Kong
Journal:  ACS Med Chem Lett       Date:  2022-02-02       Impact factor: 4.345

Review 2.  Research Advances on Anti-Cancer Natural Products.

Authors:  Meng Guo; Jie Jin; Dong Zhao; Zheng Rong; Lu-Qi Cao; Ai-Hong Li; Xiao-Ying Sun; Li-Yi Jia; Yin-Di Wang; Ling Huang; Yi-Heng Li; Zhong-Jing He; Long Li; Rui-Kang Ma; Yi-Fan Lv; Ke-Ke Shao; Hui-Ling Cao
Journal:  Front Oncol       Date:  2022-05-06       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.